alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2

CERTIFICATION BY CHIEF FINANCIAL OFFICER  PURSUANT TO 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PanAmSat Holding Corporation (the "Company") on Form 10-Q for the period ended June 30, 2005
as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael J. Inglese, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:



|Date: August 9, 2005 |  | /s/MICHAEL J. INGLESEMichael J. Inglese Executive Vice
President and
Chief Financial Officer
|-------------------- |  | --------------------------------------------------------------------------------------------

---



QuickLinks
**Exhibit 21.1**

 

**The SCO Group, Inc. Listing of Subsidiaries**

 
| **Subsidiary**                   | ** ** | **Location**   | ** ** | **Ownership Interest** |
|----------------------------------|------------|----------------|------------|------------------------|
|                             |       |           |       |                   |
| SCO Operations, Inc.             |       | United States  |       | Wholly-owned           |
| SCO Global, Inc.                 |       | United States  |       | Wholly-owned           |
| SCO Software (Ireland) Ltd.      |       | Ireland        |       | Wholly-owned           |
| SCO Software (UK) Ltd.           |       | United Kingdom |       | Wholly-owned           |
| SCO Japan, Ltd.                  |       | Japan          |       | Wholly-owned           |
| The SCO Group Korea, Inc.        |       | Korea          |       | Wholly-owned           |
| SCO Canada, Inc.                 |       | Canada         |       | Wholly-owned           |
| The SCO Group (Deutschland) GmbH |       | Germany        |       | Wholly-owned           |
| The SCO Group (France) Sarl      |       | France         |       | Wholly-owned           |
| The SCO Group (Italia) Srl       |       | Italy          |       | Wholly-owned           |

 

----
Exhibit 32.1  CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In
connection with the Annual Report on Form 10-K of EarthLink, Inc.
(the Company) for the period ended December 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Rolla
P. Huff, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to my knowledge that:  (1)the Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and  (2)the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company. /s/
  ROLLA P. HUFFRolla
  P. HuffChief
  Executive OfficerFebruary 26,
  2010
Order filed November 5, 2021 

In The

Fourteenth Court of Appeals

____________

NO. 14-21-00610-CV

____________

IN THE INTEREST OF G.C.P., A CHILD

On Appeal from the 313th District Court

Harris County, Texas

Trial Court Cause No. 2020-01821J

ORDER

This is an accelerated appeal from a judgment in a suit in which the 

termination of the parent-child relationship was ordered. The notice of appeal was 

filed October 25, 2021. Appellant has established indigence or is presumed to be 

indigent. See Tex. R. App. P. 20.1(a). The reporter’s record was due within 10 

days after the notice of appeal was filed. See Tex. R. App. P. 35.1(b); 28.4(a)(1). 

The record has not been filed.

Appeals in parental termination cases and child protection cases are to be 

brought to final disposition within 180 days of the date the notice of appeal is 

filed. See Tex. R. Jud. Admin. 6.2(a). The trial and appellate courts are jointly 

responsible for ensuring that the appellate record is timely filed. See Tex. R. App. 

P. 35.3(c). The trial court must direct the court reporter to immediately commence 
the preparation of the reporter’s record and must arrange for a substitute reporter, 

if necessary. See Tex. R. App. P. 28.4(b)(1).

Because the reporter’s record has not been filed timely in this accelerated 

appeal, we issue the following order:

We order Stephanie Wells, the official court reporter, to file the record in 

this appeal on or before November 15, 2021. If Stephanie Wells does not timely 

file the record as ordered, the court will issue an order requiring her to appear at a 

hearing to show cause why the record has not been timely filed and why she should 

not be held in contempt of court for failing to file the record as ordered. Contempt 

of court is punishable by a fine and/or confinement in jail.

PER CURIAM

Panel Consists of Chief Justice Christopher, and Justices Zimmerer and Wilson.
EXHIBIT 32.1





Section 906 Certification by the Chief Executive Officer and Chief Financial Officer




Stephen J. Schoepfer, Chief Executive Officer and Chief Financial Officer, of Carbonics Capital Corporation, a Delaware corporation (the “Company”) hereby certifies pursuant to 18 U.S.C. ss. 1350, as added by ss. 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge:




(1) The Company’s annual report on Form 10-K for the period ended December 31, 2010 (“Form 10-K”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and




(2) The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operation of the Company.





/s/ Stephen J. Schoepfer

/s/ Stephen J. SchoepferName: Stephen J. Schoepfer

Title:  Chief Executive Officer

Name: Stephen J. Schoepfer

Title: Chief Financial OfficerDate: September 29, 2011
#### Nettie GLASS, Plaintiff/Respondent, v. SHELL OIL COMPANY, Defendant/Appellant.

No. 63213.

Missouri Court of Appeals, Eastern District, Division Four.

Nov. 2, 1993.

Jennifer H. Fisher, St. Louis, for appellant.

James N. Guiri, II, St. Louis, for respondent.

Before GRIMM, P.J., and CARL R. GAERTNER and AHRENS, JJ.

PER CURIAM.

In this jury-tried case, plaintiff-customer was awarded damages for injuries she received when she fell on some ice on defendant-owner’s property. Owner appeals.

An opinion reciting the detailed facts and restating the principles of law would have no precedential value. However, the parties have been furnished with a memorandum opinion for their information only, setting forth the facts and reasons for this order.

The judgment is affirmed in accordance with Rule 84.16(b).
EX-4.2








Exhibit No. 4.2




CONSENT OF COUNSEL



To: The Board of Directors of Boralex Inc.



We hereby consent to the reference to us in Section 28 of the Circular with respect to “Certain
United States Income Tax Considerations” in the Offer and Circular dated May 18, 2010 included in
the Registration Statement on Form F-8, dated the date hereof, relating to the registration of
senior subordinated convertible debentures of Boralex Inc.




New York, New York

May 18, 2010




	 	 	 	 	 
	 	 	 
	 	                                                   /s/ K&L Gates LLP
 	 
	 	K&L Gates LLP
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Allergy, Immunology, and Transplantation Research Committee (AITC).                    

*Date:*                         June 24-25, 2021.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health 5601 Fishers Lane, Room 3G31, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31, Bethesda, MD 20892-9834, (240) 669-5060,                         *james.snyder@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: May 26, 2021.

Tyeshia M. Roberson,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-11543 Filed 6-1-21; 8:45 am]

BILLING CODE 4140-01-P
[Federal Register Volume 86, Number 109 (Wednesday, June 9, 2021)]
[Notices]
[Page 30684]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12098]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Open Meeting of the Taxpayer Advocacy Panel Taxpayer 
Communications Project Committee

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: An open meeting of the Taxpayer Advocacy Panel's Taxpayer 
Communications Project Committee will be conducted. The Taxpayer 
Advocacy Panel is soliciting public comments, ideas, and suggestions on 
improving customer service at the Internal Revenue Service. This 
meeting will still be held via teleconference.

DATES: The meeting will be held Tuesday, July 13, 2021.

FOR FURTHER INFORMATION CONTACT: Conchata Holloway at 1-888-912-1227 or 
336-690-6217.

SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to Section 
10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) 
that a meeting of the Taxpayer Advocacy Panel Taxpayer Communications 
Project Committee will be held Tuesday, July 13, 2021, at 12:00 p.m. 
Eastern Time. The public is invited to make oral comments or submit 
written statements for consideration. Due to limited time and structure 
of meeting, notification of intent to participate must be made with 
Conchata Holloway. For more information please contact Conchata 
Holloway at 1-888-912-1227 or 336-690-6217, or write TAP Office, 4905 
Koger Boulevard, Greensboro, NC 27407-2734 or contact us at the 
website: http://www.improveirs.org. The agenda will include various IRS 
issues.

    Dated: June 4, 2021.
Kevin Brown,
Acting Director, Taxpayer Advocacy Panel.
[FR Doc. 2021-12098 Filed 6-8-21; 8:45 am]
BILLING CODE 4830-01-P
EXHIBIT 13.2

                          CERTIFICATION OF ARTHUR LANG
     PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002







<PAGE>


                                  EXHIBIT 13.2

          CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
           PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of IMA Exploration  Inc. (the "Company") on
Form 20-F for the year ending  December 31, 2006,  as filed with the  Securities
and Exchange Commission on the date hereof the "Report"),  I, Arthur Lang, Chief
Financial  Officer and Director of the Company,  certify,  pursuant to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that:

         (1)      The Report fully  complies  with the  requirements  of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information  contained in the Report fairly  presents,  in
                  all material respects,  the financial condition and results of
                  operations of the Company.

A signed original of this written statement has been provided to the Company and
will be  retained  by the  Company  and  furnished  to the SEC or its staff upon
request.


/s/ Arthur Lang
------------------------------------
Arthur Lang
Chief Financial Officer and Director
[Federal Register Volume 61, Number 87 (Friday, May 3, 1996)]
[Notices]
[Page 19943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-11028]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention


Hanford Thyroid Morbidity Study Advisory Committee: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Hanford Thyroid Morbidity Study Advisory Committee.
    Times and Dates: 9 a.m.-5 p.m., May 20, 1996. 7 p.m.-9 p.m., May 
20, 1996.
    Place: Wyndham Garden Hotel, 18118 Pacific Highway South, 
Seattle, Washington 98188.
    Status: Open to the public, limited only by the space available.
    Purpose: This committee is charged with providing advice and 
guidance to the Director, CDC, regarding the scientific merit and 
direction of the Hanford Thyroid Morbidity Study.
    The Committee will review development of the study protocol and 
recommend changes of scientific merit to CDC, advise on the conduct 
of the pilot study using the approved protocol, and assist in 
determining the feasibility of a full-scale epidemiologic study. If 
the full-scale epidemiologic study is carried out, the Committee 
will advise CDC on the design and conduct of the study and analysis 
of the results.
    Matters To Be Discussed: The Committee will discuss the progress 
and updates of the status of various components of the Hanford 
Thyroid Disease Study being conducted by the Fred Hutchinson Cancer 
Research Center. Agenda items include: National Center for 
Environmental Health (NCEH) activities on the progress of current 
studies, an update on the Native American component, and public 
involvement activities. On May 20, at 7 p.m., the meeting will 
continue in order to allow more time for public input and comment.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Nadine Dickerson, Program 
Analyst, Radiation Studies Branch, Division of Environmental Hazards 
and Health Effects, NCEH, CDC, 4770 Buford Highway, NE, (F-35), 
Atlanta, Georgia 30341-3724, telephone 770/488-7040.

    Dated: April 29, 1996.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 96-11028 Filed 5-2-96; 8:45 am]
BILLING CODE 4163-18-M
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 19, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-6238

BorgWarner, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request concerns a product strategically important or related to 

‘‘Made in China 2025’’ or other Chinese industrial programs.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
<PAGE>


Exhibit 99
----------

Company Name Change

     Effective May 10, 2000 the Company changed its name to Premcor USA Inc.
from Clark USA, Inc. In connection with this name change, the following
affiliated companies have also changed their names:

  New Name                            Former Name
  --------                            -----------

Parent Company:
  Premcor Inc.                        Clark Refining Holdings Inc.

Subsidiaries:
  Premcor Investments Inc.            Clark Investments, Inc.
  Premcor P.A. Pipeline Company       Clark Port Arthur Pipe Line Company
  The Premcor Pipeline Co.            Clark Pipe Line Company
  The Premcor Refining Group Inc.     Clark Refining & Marketing, Inc.
EXHIBIT 31.2

                                  CERTIFICATION

I, Chuen Huei (Kevin) Lee, Chief Financial Officer of Bio-Bridge Science, Inc.,
(the "Company), certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Bio-Bridge Science,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.



Date: November 14, 2005

/s/ Chuen Huei (Kevin) Lee
--------------------------
By:  Chuen Huei (Kevin) Lee
Chief Financial Officer
CERTIFICATION PURSUANT TO
         18 U.S.C. SECTION 1350
          AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cross Atlantic Commodities,
Inc. (the "Company") on Form 10-QSB for the three months ended March
31, 2007 as filed with the Securities and Exchange Commission on the
date hereof (the "Report"), I, Michael Enemaerke, Chief Executive
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
            (1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
           (2) The information contained in the Report fairly presents,
in all material respects, the financial condition and result of
operations of the Company.

/s/Michael Enemaerke
-----------------------------
Michael Enemaerke
Chief Executive Officer

May 8, 2007


        CERTIFICATION PURSUANT TO
         18 U.S.C. SECTION 1350
          AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cross Atlantic Commodities,
Inc. (the "Company") on Form 10-QSB for the three months ended March
31, 2007 as filed with the Securities and Exchange Commission on the
date hereof (the "Report"), I, Kim Beck-Nielsen, Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
            (1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
           (2) The information contained in the Report fairly presents,
in all material respects, the financial condition and result of
operations of the Company.

/s/ Kim Beck Nielsen
-----------------------------
Kim Beck Nielsen
Chief Financial Officer

March 8, 2007
#### STATE of Missouri, Respondent, v. Carmichael KEY, Appellant. Carmichael KEY, Appellant, v. STATE of Missouri, Respondent.

Nos. WD 47843, WD 50450.

Missouri Court of Appeals, Western District.

June 27, 1995.

Ellen H. Flottman, Office of the State Public Defender, Columbia, for appellant.

Jeremiah W. (Jay) Nixon, Atty. Gen., Mary Moulton Bryan, Asst. Atty. Gen., Jefferson City, for respondent.

Before HANNA, P.J., and BERREY and SPINDEN, JJ.

*ORDER*

PER CURIAM:

Appellant appeals his conviction of murder in the first degree, § 565.020.1, RSMo.1986, sentence of life imprisonment without parole, and denial of his Rule 29.15 motion for post conviction relief.

Affirmed. Rules 84.16(b) and 30.25(b).